New & Noteworthy

Nov 30, 2017
Mark Bouch, Stephen Bungay, and David Roblin outline how the technique of "mission command", a military approach to setting direction and executing strategy in the pharmaceutical industry, has developed over the last ten years.
Nov 30, 2017
Pharmaceutical Executive
Analysis shows that persistence is paying off for drug developers, driven by the rise of CAR-T and other gene therapy, newly discovered cancer targets, better patient identification methods.
Nov 27, 2017
Halfway through the process for establishing a national electronic drug tracking system, there’s concern among pharma companies, distributors, and pharmacists about meeting the 2023 deadline
Nov 20, 2017
While the GAIN Act's Qualified Infectious Disease Product (QIDP) designation program has been successful in driving innovation, commercial viability remains a question.
Nov 20, 2017
Abigail Bernardi explains how a better understanding of connections among practitioners on care teams helps sales reps build relationships while benefitting a company’s marketing efforts.
Nov 13, 2017
Pharmaceutical Executive
With its convergence of healthcare talent and tech, the nation is turning into a prime destination for innovative startups.
Nov 12, 2017
Prognos CEO Sundeep Bhan talks about how the company’s unique offering will reach beyond life sciences as the long-promised benefits of AI become reality.
Nov 07, 2017
While most pharma companies are in partial production using generators, few are operating at 100% capacity, writes Jill Wechsler.
Nov 06, 2017
Pharmaceutical Executive
Can health stakeholders be friends without being captives? Reflector reports.
Oct 31, 2017
Pharmaceutical Executive
Pharm Exec’s 10th annual list of rising leaders highlights 11 pharma managers who are poised to help chart the industry’s path forward.
native1_300x100
lorem ipsum